Even if EMEA approves the drug, in the UK that only means private doctors can prescribe then, which aren't that many. For the government doctors to prescribe, the drug has to go through more red tape evaluations, etc, which includes Value for the Money and cost effectiveness evaluations, etc. And many private doctors get set in their ways, prescribing things they are familiar with. The old adage is never be the first nor the last to try something. For many doctors, the standard treatments will stay the norm. Any longs believing sales will take off immediately are delusional. Sales will be sparse for years to come.
The revenues presented at the confererence are first based on eu approval. 2nd mkting will not initiate till the end of this yr which means earliest revenue 2012 "if" eu approves. 3rd: fda wants more testing till mid year! Fact! And now we have fibro gen which is written up which a significant % of fda approval. What else do you need dummies!